Cairn Terriers are small, hardy Scottish terriers with an energetic disposition and a health profile shaped by several conditions specific to this breed. Most owners are aware of the allergy susceptibility — Cairns are among the most atopy-prone terrier breeds. Fewer are prepared for the neurological and hepatic conditions that can present in young Cairns, particularly portosystemic shunts and globoid cell leukodystrophy, both of which carry significant supplement management implications.

Portosystemic shunts (PSS)

A portosystemic shunt is a vascular anomaly in which blood from the gastrointestinal tract bypasses the liver and drains directly into systemic circulation. The liver normally filters this blood — removing ammonia, metabolizing toxins, producing clotting factors and albumin, and clearing gut-derived bacteria. When blood bypasses the liver, these functions fail proportionally to the degree of shunting.

In Cairn Terriers, congenital extrahepatic shunts predominate — typically a single abnormal vessel connecting the portal vein to the caudal vena cava or azygous vein. Clinical signs emerge in puppies and young dogs: stunted growth, post-meal neurological signs (hepatic encephalopathy — circling, head pressing, apparent blindness, seizures), polyuria, polydipsia, and urinary tract issues from ammonium urate crystal formation. Diagnosis is by bile acid stimulation testing and abdominal ultrasound or nuclear scintigraphy. Treatment options include surgical or interventional attenuation of the shunt vessel, which is curative in many dogs.

The supplement constraint in PSS dogs is critical: High-protein supplements and free-form amino acid supplements are contraindicated in dogs with active portosystemic shunts. Dietary protein is the primary ammonia source — gut bacteria degrade amino acids to ammonia, which then enters portal blood. In a dog with a shunt, this ammonia bypasses hepatic urea-cycle processing and accumulates systemically, directly causing hepatic encephalopathy. Protein supplements, amino acid blends, colostrum in large amounts, and high-protein meal toppers all increase this risk. All supplementation decisions in PSS-affected Cairns must be vet-guided. The veterinarian managing the shunt determines protein intake targets and any supplemental additions.

Globoid cell leukodystrophy (Krabbe disease)

Globoid cell leukodystrophy is a lysosomal storage disease caused by deficiency of galactocerebrosidase (GALC), an enzyme required to degrade galactocerebroside in myelin. Without functional GALC, galactocerebroside accumulates in globoid cells — macrophages in the central and peripheral nervous system — causing progressive demyelination. In Cairn Terriers (and West Highland White Terriers), the condition is autosomal recessive with a known causative mutation.

Clinically, affected puppies are normal at birth and begin showing signs between 2 and 6 months: ataxia, progressive weakness, difficulty swallowing, visual deficits, and eventually seizures. The condition is uniformly fatal, typically within weeks to months of symptom onset. There is no treatment. A DNA test identifies affected (two copies), carrier (one copy), and clear (no copies) status. Responsible breeding programs test all Cairns used for breeding. No supplement intervention has any role in this condition.

Ocular melanosis (pigmentary uveitis)

Cairn Terriers are predisposed to ocular melanosis — abnormal proliferation of melanocytes within the anterior uveal tract, leading to pigmentary uveitis, increased intraocular pressure, and in some cases secondary glaucoma. The condition is progressive and can result in vision loss. It is managed ophthalmologically; omega-3 at appropriate doses supports general ocular surface health and may modestly influence aqueous humor dynamics, but this is adjunctive support, not treatment.

Allergic skin disease

Atopic dermatitis is the most common clinical presentation in Cairns in general practice. Environmental allergens — grass, pollen, dust mites — drive chronic pruritus, recurrent ear infections, paw licking, and interdigital inflammation. The gut-skin connection is mechanistically relevant: gut dysbiosis amplifies systemic inflammatory tone and allergic sensitization. Omega-3 reduces inflammatory cytokines; quercetin provides mast cell stabilization and mild antihistamine effect; probiotics support the gut-immune calibration that influences allergic threshold.

The Cairn Terrier supplement protocol

• Omega-3 EPA+DHA — for allergy, skin barrier, and immune support. Safe in non-PSS dogs at standard therapeutic doses
• Quercetin + bromelain — for atopic dermatitis; no hepatic or protein concerns at standard doses
• Probiotics — gut-immune calibration; a low-risk, high-relevance addition for atopic Cairns. Use a well-characterized canine strain product
• In PSS dogs: all supplementation deferred to veterinary guidance. Avoid protein supplements, amino acid supplements, and high-protein toppers. Focus is on ammonia management and liver function support as directed by the treating vet
• Biotin and zinc — for coat and skin support; appropriate in non-PSS dogs

All Cairns used in breeding should be DNA-tested for globoid cell leukodystrophy. Any Cairn puppy showing neurological signs before 6 months should be assessed urgently — both PSS and Krabbe disease are on the differential.

Related: liver supplement guide · allergy supplement guide · probiotics for dogs · omega-3 for dogs · skin supplement guide.